AssureDrop
Founded 2024 · 3 employees on LinkedIn · 1 known investors
AssureDrop develops droplet microfluidics-based screening technology that works within standard multiwell plates for pipette-free, high-throughput screening of 3D cell models such as spheroids. It targets biotechnology and cancer research applications including drug discovery, personalized medicine, and genetic analysis using limited biological samples like patient biopsies and stem cells.
Founders & leadership
AssureDrop was founded in 2024 by Ankur Chaurasia.
AC
Ankur ChaurasiainFounder
Investors · 1
Frequently asked questions
- What does AssureDrop do?
- AssureDrop develops droplet microfluidics-based screening technology that works within standard multiwell plates for pipette-free, high-throughput screening of 3D cell models such as spheroids. It targets biotechnology and cancer research applications including drug discovery, personalized medicine, and genetic analysis using limited biological samples like patient biopsies and stem cells.
- Who founded AssureDrop?
- AssureDrop was founded by Ankur Chaurasia in 2024.
- Who are AssureDrop's investors?
- AssureDrop's investors include Fifty Years.